Industry Sponsored Sessions
-
Tripartite Meeting
- 19th Meeting of the European Venous Forum
- 9th Annual Meeting of the Balkan Venous Forum
- Hellenic Phlebological Society Summit
- Olympia Hall, Royal Olympic Hotel, Athens, Greece
- 28-30 June 2018
THURSDAY 28 JUNE 2018
| 11.00-12.00 | Industry Session supported by a grant from Pierre Fabre
CVD: From Symptoms to Microcirculation Chair: Andrew Nicolaides (Cyprus) |
|
11.00-11.20 |
What symptoms mean and how they influence our choice of investigations. Marianne De Maeseneer (Belgium) |
|
11.20-11.40 |
Is there a link between symptoms and microcirculation alternations? Bernardo Barros (Brazil)
|
|
11.40-12.00 |
How to choose the right VAD for the right patient, based on updated EVF Guidelines? Stavros Kakkos (Greece) |
|
|
|
| 14.20-15.20 | Industry Session supported by a grant from Alfasigma
CVD: Beyond Signs and Symptoms. Therapeutic Advances Chair: Armando Mansilha (Portugal), Jawed Fareed (USA) |
| 14.20 | CVD. A complex disorder. Andrew Nicolaides (Cyprus) |
| 14.40 | Underlying factors in CVD evolution. Ferdinando Mannello (Italy) |
| 15.00 | Sulodexide for signs, symptoms and beyond. Tomasz Urbanek (Poland) |
FRIDAY 29 JUNE 2018
| 11.00-12.00 | Industry Session supported by a grant from Servier Burden and Suffering in Chronic Venous Disease Chair: Nicos Labropoulos (USA), Andrew Nicolaides (Cyprus) |
| 11.00 | Introduction. Nicos Labropoulos (USA) |
| 11.03 | Real world evidence: The seriousness of chronic venous disease. Alun H Davies (UK) |
| 11.18 | How does chronic venous disease progress from the first symptoms to the advanced stages? Nicos Labropoulos (USA) |
| 11.33 | MPFF for patients suffering from chronic venous disease: New evidence. J-H Ulloa (Colombia) |
| 11.48 | Discussion |
| 11.58 | Concluding remarks. Andrew Nicolaides (Cyprus) |